A bioinformatics-to-clinic sequential approach to analysis of prostate cancer biomarkers using TCGA datasets and clinical samples: a new method for precision oncology?

Biomarker-driven cancer therapy has met with significant clinical success. Identification of a biomarker implicated in a malignant phenotype and linked to poor clinical outcome is required if we are to develop these types of therapies. A subset of prostate adenocarcinoma (PACa) cases are treatment-r...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshie, Hidekazu, Sedukhina, Anna S., Minagawa, Kimino, Oda, Keiko, Ohnuma, Shigeko, Yanagisawa, Nobuyuki, Maeda, Ichiro, Takagi, Masayuki, Kudo, Hiroya, Nakazawa, Ryuto, Sasaki, Hideo, Kumai, Toshio, Chikaraishi, Tatsuya, Sato, Ko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725118/
https://www.ncbi.nlm.nih.gov/pubmed/29245927
http://dx.doi.org/10.18632/oncotarget.20448

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725118/
https://www.ncbi.nlm.nih.gov/pubmed/29245927
http://dx.doi.org/10.18632/oncotarget.20448

Ejemplares similares